Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-osteoporosis therapies for repair of osteoporotic fractures
IRCT20160830029603N6Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in osteoporosis comparing Calcium + vitamin D + teriparatide, Calcium + vitamin D + alendronate and Calcium + vitamin D control (3 arms). Primary endpoint: Rate of fracture restoration. Started Mar 2017; status: completed.
02
Drugs
teriparatidealendronatecalciumvitamin d
03
Conditions
osteoporosis
Beyond the preview
Go deeper on IRCT20160830029603N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160830029603N6.